Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 100.51 USD 0.71% Market Closed
Market Cap: 7.1B USD
Have any thoughts about
Zealand Pharma A/S?
Write Note

Wall Street
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 146.9 USD with a low forecast of 117.33 USD and a high forecast of 164.63 USD.

Lowest
Price Target
117.33 USD
17% Upside
Average
Price Target
146.9 USD
46% Upside
Highest
Price Target
164.63 USD
64% Upside
Zealand Pharma A/S Competitors:
Price Targets
KNSA
Kiniksa Pharmaceuticals Ltd
78% Upside
ARGX
argenx SE
3% Downside
4593
Healios KK
119% Upside
2162
KeyMed Biosciences Inc
87% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
29% Upside
VITR
Vitrolife AB
31% Upside
COYA
Coya Therapeutics Inc
204% Upside
TGTX
TG Therapeutics Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is 8%. The projected CAGR for the next 4 years is 56%.

8%
Past Growth
56%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZLDPF's stock price target?
Price Target
146.9 USD

According to Wall Street analysts, the average 1-year price target for ZLDPF is 146.9 USD with a low forecast of 117.33 USD and a high forecast of 164.63 USD.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
56%

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is 8%. The projected CAGR for the next 4 years is 56%.

Back to Top